Bocunebart's PACAP-targeting mechanism positions it as a potential first-in-class therapy in a thin pipeline of novel late-stage candidates.

New data from LivaNova has demonstrated the clinical benefit of its programming algorithm in patients with obstructive sleep apnoea (OSA). Trial data demonstrated that the company’s PolySync ...

LIVN's PolySync data show an 84.5% AHI response rate in OSA patients, building on OSPREY results for its aura6000 System.

Some Québec clinics might soon use AI-powered technology to more quickly test patients for dry eye syndrome and help doctors ...

New York is regulating targeted pricing algorithms to ensure transparency and prevent discrimination. The 2025 APDA requires ...

KFSH Jeddah's Single-Session Stem Cell Protocol Sets a New Global Standard Balancing Donor Safety and Treatment ...

The Institute for Applied Health Intelligence would explore transition from promising trials to full implementation.

The rule, released Thursday, builds on Trump administration’s priorities, including cutting Medicare reimbursement for drugs ...

AI is rapidly reshaping biomedical research, but practitioners agree that AI’s success depends on more than advanced algorithms.

King Faisal Specialist Hospital and Research Centre in Jeddah has successfully developed and implemented the world's first protocol of ...

Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.

For decades, treating depression has largely involved a difficult form of medical guesswork: prescribing one antidepressant after another in hopes that one will eventually help. A new study led by ...